H.M. Sampoerna Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? H.M. Sampoerna Tbk. trades at Rp730 (market cap 86.08T, 6.17M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: H.M. Sampoerna Tbk. is far larger — about 124.5× UBC Medical Indonesia Tbk.'s market cap, and H.M. Sampoerna Tbk. is more actively traded (6.17M versus 635.5K). Which is the better fit depends on your goals.
| HMSP | LABS | |
|---|---|---|
Market Cap | 86.08T | 691.25B |
Volume | 6.17M | 635.5K |
Lot | 61.7K | 6.36K |
Turnover | 4.52B | 110.15M |
Average Price | 732.19 | 173.33 |
Value | 4.52B | 110.15M |
Indicative Equilibrium Price | 730 | 174 |
Indicative Equilibrium Volume | 3.68K | 50 |
Trailing returns across standard periods
Latest headlines on both assets
PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.
Read more on HMSP →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →